Kupatawintu P, Nathalang O, Charoen RO, Patmasiriwat P. Gene frequencies of the HPA-1 to 6 and Gov human platelet antigens in Thai blood donors. Immunohematology 2005; 21(1): 5-9.
Shaiegan M, Amiri F, Derakhti Gonbad MH, Aghaeipour M, Maghsudlu M, Tabatabaian A, et al. Flowcytometric evaluation of antibodies against histocompatibility antigens and platelet-specific antigens in patients with hematological disorders following the transfusion of platelets concentrates. Sci J Iran Blood Transfus Organ 2005; 1(2): 27-36. [Article in Farsi]
Philip J, Kumar S, Chatterjee T, Mallhi RS. Prevalence of Alloimmunization to Human Platelet Antigen Glycoproteins and Human Leucocyte Antigen Class I in beta Thalassemia Major Patients in Western India. Indian J Hematol Blood Transfus 2014; 30(4): 309-12.
Ficko T, Galvani V, Rupreht R, Dovc T, Rozman P. Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSP method. Transfus Med 2004; 14(6): 425-32.
Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990; 75: 408-13.
Fabris F, Soini B, Sartori R, Randi ML, Luzzatto G, Girolami A. Clinical and laboratory factors that effect the post transfusion platelet increment. Transfus Sci 2000; 23(1): 63-8.
Halle L, Bigot A, Mulen-Imandy G, Bayo K, Jaeger G, Anani L, et al. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens 2005; 65(3): 295-8.
Sarkar RS, Philip J, Jain N. Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) technique and its correlation to platelet refractoriness in multi platelet concentrate transfused patients. Indian J Hematol Blood Transfus 2015; 31(1): 77-84.
Bianchi J, Azevedo M, Jens E, Nukui Y, Chamone D. Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions. Rev Bras Hematol Hemoter 2012; 34(3): 202-5.
Kiefel V, Kroll H, Santoso S. Platelet alloantibodies in transfused patients. Transfusion 2001; 41: 766-70.
Zimmermann R, Wittmann G, Zingsem J, Blasczyk R, Weisbach V, Eckstein R. Antibodies to private and public HLA class I epitopes in platelet recipients. Transfusion 1999; 39(7): 772-80.
Bub CB, Martinelli BM, Avelino TM, Gonçalez AC, Barjas-Castro Mde L, Castro V. Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness. Rev Bras Hematol Hemoter 2013; 35(4): 252-5.
Nozari M, Zadsar M, Shaiegan M, Samiee S. Iranian Turkmen blood donors determining the HPA-1 gene frequency in 1397. Sci J Iran Blood Transfus Organ 2019; 17(1): 12-9. [Article in Farsi]
Madani T, Samiee Sh, Attaei Z, Kavari M, Mostkademin M, Shaiegan M. Platelet antigens frequency in blood donors: comparison of molecular detection with ELISA method (for HPA-1a ). Sci J Iran Blood Transfus Organ 2007; 4(3): 165-74. [Article in Farsi]
Mostakhdemin Hosseini M, Samiee S, Shaiegan M,
Mohammadi S, Jalaiekhoo H, Tabatabiepanah P, et al. Evaluation of platelet antigens and antibodies in patients with platelet refractoriness. Scientific Journal of Iran Blood Transfus Organ 2019; 16(2): 91-102. [Article in Farsi]
Halle L, Bigot A, Mulen-Imandy G, Bayo K, Jaeger G, Anani L, et al. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens 2005; 65(3): 295-8.
Kulkarni B, Mohanty D, Ghosh K. Frequency distribution of human platelet antigens in the Indian population. Transfus Med 2005; 15(2): 119-24.
Sci J Iran Blood Transfus Organ 2020;17 (4): 294-307
Original Article
Platelet antigens and antibodies in multitransfused patients Ebrahimzadeh E.1, Alaei M.1, Samiee Sh.1, Shaiegan M.1 1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran Abstract Background and Objectives
Following incompatible blood transfusions, anti-HLA and anti- HPA antibodies may develop and cause various disorders such as post-transfusion purpura, platelet refractoriness, and thrombocytopenia leading to bleeding. The aim of this study was to investigate platelet antigens and antibodies in multi-transfused patients.
Materials and Methods
In this descriptive study, platelet antigens and presence of platelet antibodies were tested by PCR-SSP and PIFT flowcytometry in 30 Thalassemia major and 30 oncohematologic patients with one hour post transfusion platelet counts in the range of 150000-450000/µl. χ2 test was employed for comparing the results of the study.
Results
Molecular genotyping of HPA-1in thalassemia major patients and patients with oncohematologic disorder in this study revealed that HPA-1a/1a was the most and HPA-1a/1b and HPA-3b/3b were the least frequent genotypes. No homozygous cases of 1b/1b, 2b/2b and 5b/5b were detected. HPA-4b allele was not detected in any patient. Flow PIFT results revealed platelet antibodies in 10(30%) patients with hematologic disorders and 1(3.3%) thalassemia major patients. Conclusions
According to %100 frequency of HPA-4a and total absence of HPA-4b allele and absence of homozygous b/b genotype for HPA-1/-2/-5 alleles in the patient polulation of this study, the prevalence of platelet alloimmunization due to antibodies against these antigens seems to be low. Although further studies in the field are nessessary.
Key words: Platelets, Antigens, Antibodies, PCR
Received: 7 Oct 2020 Accepted:15 Dec 2020
Correspondence: Alaei M., MD. Pathologist. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052234; Fax: (+9821) 88628741
E-mail: alaeimastaneh@hotmail.com
Ebrahinzadeh E, Alaei M, Samiee S, Shaiegan M. Platelet antigens and antibodies in multitransfused patients. Sci J Iran Blood Transfus Organ 2020; 17 (4) :294-307 URL: http://bloodjournal.ir/article-1-1376-en.html